BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 247 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $27,284,000 | +74.6% | 197,980 | +76.0% | 0.06% | +65.7% |
| Q3 2021 | $15,630,000 | +10.3% | 112,517 | -22.9% | 0.04% | +9.4% |
| Q2 2021 | $14,174,000 | +42.0% | 146,000 | 0.0% | 0.03% | +28.0% |
| Q1 2021 | $9,979,000 | -26.6% | 146,000 | -8.0% | 0.02% | -26.5% |
| Q4 2020 | $13,600,000 | +35.6% | 158,675 | +2.9% | 0.03% | +9.7% |
| Q3 2020 | $10,029,000 | -9.4% | 154,275 | +1.9% | 0.03% | -22.5% |
| Q2 2020 | $11,067,000 | +114.9% | 151,375 | 0.0% | 0.04% | +60.0% |
| Q1 2020 | $5,151,000 | +2101.3% | 151,375 | +3420.3% | 0.02% | +2400.0% |
| Q4 2019 | $234,000 | – | 4,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 1,111,111 | $107,867,000 | 52.60% |
| Knoll Capital Management, LLC | 856,844 | $83,182,000 | 43.44% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,082,555 | $202,174,000 | 27.86% |
| ARS Investment Partners, LLC | 558,286 | $54,198,000 | 5.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $17,113,000 | 4.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 401,006 | $38,930,000 | 4.51% |
| Eventide Asset Management | 1,990,797 | $193,267,000 | 2.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 56,626 | $5,497,000 | 2.45% |
| Avidity Partners Management LP | 882,500 | $85,673,000 | 2.32% |
| Nicholas Investment Partners, LP | 363,708 | $35,309,000 | 2.22% |